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Abstract
Background: The diagnosis of lung typical carcinoid tumors results challenging when limited size and unfavorable
sampling location is associated. It has been reported that bronchoscopy with endobronchial ultrasound (EBUS)
significantly increases the diagnostic yield of peripheral nodules smaller than 2 cm.
Case presentation: A 70-year-old Caucasian male complained of persistent fever and cough despite several
antibiotic courses and steroid treatment. Chest radiology revealed the presence of a small single nodular opacity in
the left upper lobe, whose standardized maximum uptake value (SUV) at fluorodeoxyglucose positron emission
tomography-computed tomography (FDG PET/CT) was significantly high (4.5). The patient underwent bronchial
endoscopy but any appreciable sign of endobronchial or intramural involvement was detected. Only radial
ultrasound-guided bronchoscopy (R-EBUS) allowed transbronchial sampling whose pathological analysis revealed a
typical carcinoid tumor. The patients underwent surgical lobectomy and clinic-radiological follow was started.
Conclusions: With this case we aim at stressing the importance of ultrasound in the diagnostic process of lung
small peripheral carcinoid, especially if they present without mucosal or sub mucosal involvement.
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Introduction
Carcinoid tumors are low-grade neuroendocrine ma-
lignancies that usually affect the gastrointestinal tract
[1]. According to the mitosis number (below or
above 2 mitoses/2 mm2) and the absence/presence of
architectural disruptions and necrosis found on
histopathology, they are classified as typical and
atypical carcinoid tumors respectively [2]. Pulmonary
location is reported as the second commonest site
with higher prevalence in the central bronchial tract
[3]. When situated in peripheral lung regions an ac-
curate diagnosis may result more difficult due to un-
favorable sampling position and often require
surgical excision [4]. Furthermore these lesions are
usually size-limited and highly vascularized with the
bronchial mucosa that overlays the carcinoid rela-
tively spared: these features contribute to make the
diagnosis even more challenging. [5]. It has recently
been reported that bronchoscopy with endobronchial
ultrasound (EBUS) significantly increases the diagnos-
tic yield in the evaluation of peripheral nodules
smaller than 2 cm [6]. Here we report the case of
lung peripheral typical carcinoid tumor that was not
identified at the fiber optic preliminary endoscopic in-
vestigation and whose diagnosis was made possible
only through radial endobronchial ultrasound-guided
bronchoscopy (R-EBUS).
Case presentation
A 70-year-old mild former smoker (3 packs/year)
male was admitted to the Respiratory Ward of the
Santa Maria Nuova Hospital of Reggio Emilia (IT) for
persistent cough and fever despite prolonged anti-
biotic courses and steroid therapy. Past medical his-
tory revealed surgical excision of the right vocal cord
for a benign vocal cords tumor performed 30 years
before. At the time of hospital admission the chest X
ray showed a single lung nodular opacity of 1.6 × 1.3
cm in the left upper lobe that was confirmed by a
subsequent chest computed tomography (CT) scan
(Fig. 1a). The fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/TC)
showed a single area of increased metabolic rate
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: taddei.sofia@ausl.re.it; sofia.taddei@ausl.re.it
1Respiratory Diseases Unit, Azienda Unità Sanitaria Locale - IRCCS Arcispedale
Santa Maria Nuova, Reggio Emilia, Viale Risorgimento 80, 42123 Reggio
Emilia, Italy
Full list of author information is available at the end of the article
Piro et al. BMC Pulmonary Medicine          (2019) 19:168 
https://doi.org/10.1186/s12890-019-0929-0
(maximum standardized uptake value (SUV) of
4.5) in the anterior segment of the left upper lobe
while abdomen and brain CT scan were negative
for other lesions (Fig. 1b). The patient underwent
bronchial video-endoscopy (Olympus BF-H190)
that did not identify any endobronchial or intra-
mural alterations in the explorable tracheo-bron-
chial tree. In particular no signs of mucosal
abnormalities or evidence of sub-mucosal lesions
were described (Fig. 2). Thus a radial endobronchial
ultrasound probe (REBUS) was necessary to identify
the sub-segmental bronchus were the nodule was lo-
cated and 5 trans-bronchial biopsies were performed
in the apical tract of the anterior segmental bronchus
of the left upper lobe (LB3a) (Fig. 2), with oval fenes-
trated biopsy forceps (Olympus model no. FB- 231D),
without significative bleeding or other complications.
Immunohistochemical investigation was broadly posi-
tive for chromogranin and synaptophysin while the
proliferative index assessed by KI67/MIB1 was about
1% (Fig. 3). To complete diagnosis a 68Ga-DOTA-
peptide PET/CT was also performed demonstrating a
very small area of hyper-folding of the tracer (SUV
max equal to 1.6). Based on these results the diagno-
sis of typical carcinoid of the bronchus stage cT1 cN0
cM0 was made. The patient successfully underwent
surgical excision of the upper left lobe and clinic-
radiological follow-up was started.
Discussion
Pulmonary carcinoid tumors are low-grade malignant
tumors of neuroendocrine origin [7] accounting for
Fig. 1 Panel a. Chest computed tomography (CT) scan (panel a) showing a single nodular opacity of 1.6 × 1.3 cm in the anterior segment of the
left upper lobe. Panel b. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) showing a nodular area of
increased metabolic rate located in the same area of the CT-identified lung opacity
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about 1% of all primary lung cancer [8]. In the last 3
decades, the incidence of lung carcinoid tumors has
significantly raised, probably due to increased clinical
awareness and to the improved diagnostic yield of
radiologic and endoscopic procedures [9]. On CT
scan peripheral carcinoid tumors usually present as a
single lobulated lesion whose diameter rarely exceeds
2 cm. In some studies, 68-Gallium DOTATATE pep-
tide PET-CT -a type of functional imaging in which a
radioisotope-labeled somatostatin analog peptide binds
to the somatostatin receptor found in carcinoid– has
been found to improve the anatomic localization of
neuroendocrine tumors [10]. Nevertheless, the small
size and the unfavorable sampling features of these
lesions cause that more than 30% of carcinoid tumors
require thoracotomy to be diagnosed [6]. CT-guided
needle biopsy might also be performed even though
the diagnostic yield is moderately low and pneumo-
thorax has been reported as a not infrequent compli-
cation for this procedure [6, 9]. When carcinoids are
centrally located, bronchoscopy plays a critical role in
their diagnosis, as they are visible at endoscopic
evaluation [11, 12]. Generally flexible bronchoscopy is
preferable; however, in patients at high risk for bleed-
ing, rigid bronchoscopy may be indicated, both for
obtaining biopsy specimens and also for performing
ablation procedures [11]. If carcinoids involve the
peripheral region of the lung, diagnosis results more
challenging giving the difficulty to find the right
tributary distal bronchial segment, and thoracoscopic
resection is often the method of choice. US-guided
bronchoscopy demonstrates a high diagnostic yield
with low complication rate in the diagnostic evalu-
ation of small peripheral nodules [6]. Tanaka et al.
have recently reported a case of EBUS-diagnosed per-
ipheral carcinoid tumor [11]. The authors show how
the use of ultrasound technique confirmed the pres-
ence of a solid nodule located where endoscopic
evaluation found a yellow sub-mucosal lesion. In our
case the R-EBUS technique was essential to find the
correct place to sample giving the lack of appreciable
endobronchial involvement at mucosal or sub-mucosal
level. It is worth noticing that peripherally radial
ultrasound did not help in understanding the o’clock
position of a lesion in order to guide the biopsy.
However, when the lesion occupies an important por-
tion of the bronchus lumen, this limitation could be
overcome by the precise identification of the right
tributary bronchus and the appropriate distance from
the tip of the endoscope. When forceps are pushed in
the point previously identified whit the ultrasound
probe, the biopsy can be confidently performed and
the rate of positivity is generally high. This limitation
is greater when the lesion occupies only a small
Fig. 2 Radial probe endobronchial ultrasound image in LB3a bronchus indicating the presence of a hypoechogenic nodule from 1 ‘clock to
3 o’clock
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portion of the distal bronchus or when needle is used
instead of forceps.
In conclusion, we report a case of a peripherally lo-
cated carcinoid tumor whose diagnosis was made pos-
sible only through transbronchial biopsy performed with
R-EBUS. This case emphasizes how ultrasound is more
than useful in the diagnostic process of lung small per-
ipheral tumors, particularly when they present as occult
at endoscopic investigation.
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